Trial Profile
Tolvaptan Treatment to Reverse Worsening Outpatient Heart Failure: Possible Role of Copeptin In Identifying Responders (TROUPER)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2022
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema; Dyspnoea; Heart failure
- Focus Pharmacodynamics
- Acronyms TROUPER
- 22 Jul 2021 Status changed from recruiting to completed.
- 17 Jun 2020 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.
- 17 Jun 2020 Planned primary completion date changed from 1 Mar 2020 to 1 Mar 2021.